{
  "docId": "019de073-bfd4-723b-805d-c3152d3a00ff",
  "docSlug": "7df1d9bdbc08777b7243fabbc766ed39",
  "documentTitle": "Immatics | Results Presentation Deck | 25 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 17,
  "pageCount": 25,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bfd4-723b-805d-c3152d3a00ff/17",
  "deckHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff",
  "deckJsonHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff.json",
  "deckAnchorHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.2,
        "y": 0.83
      },
      "kind": "callout",
      "text": "Data highlight the clinical potential of IMA203 TCR-T to achieve meaningful benefit for a large patient population",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b41e0ed5-a3aa-4653-93ea-35e74a3f8273",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "list",
      "text": "IMA203 continues to be well tolerated with manageable safety profile; Confirmed responses across a broad spectrum of different solid tumor types in heavily pre-treated patients; Positively evolving durability profile; Clinical validation of PRAME biomarker",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f740fe4-282f-4d12-893e-05ed3721a9e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.04,
        "y": 0.6
      },
      "kind": "list",
      "text": "Transition to indication-specific development strategy; Three Phase 1b expansion cohorts ongoing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1bf0395-c062-4340-8b68-0db9a29486cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "title",
      "text": "ACTengine® IMA203 Targeting PRAME Offers a Unique Opportunity for Solid Cancer Patients",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8d7f9cb-e68b-48ae-92a0-806bc0dc8026",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "IMA203 Monotherapy – Conclusions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd65138c-785b-42bf-8a87-8b11e1871e00",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 9,
      "beatId": "3c0d3c19-4cb2-45ea-940b-4a17ae6aecd2",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-17 present the interim clinical data and results of ACTengine IMA203.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 16,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "05862a2d-ddc7-4a3d-903b-2c79bb70aab4",
      "evidence": "Slides 16-18 discuss market potential and clinical benefit.",
      "position": 1,
      "objective": "Highlight potential for large patient population",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}